We are live on ! Find out more
LC

Lindbrook Capital Portfolio holdings

AUM $1.08B
1-Year Est. Return 10.14%
This Fund
S&P 500
This Quarter Est. Return
+4.35%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
AUM
$1.06B
AUM Growth
-$4.21M
Cap. Flow
-$36.2M
Cap. Flow %
-3.4%
Top 10 Hldgs %
45.51%
Holding
2,874
New
227
Increased
1,384
Reduced
630
Closed
115

Top Sells

Rank Stock Value
1
OCSL icon
Oaktree Specialty Lending
OCSL
+$12.7M
2
NVDA icon
NVIDIA
NVDA
+$6.29M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$3.66M
4
AAPL icon
Apple
AAPL
+$3.19M
5
AVGO icon
Broadcom
AVGO
+$2.17M

Sector Composition

Rank Sector Weight
1 Technology 17.21%
2 Financials 12.25%
3 Healthcare 6.29%
4 Communication Services 4.39%
5 Consumer Discretionary 3.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XFLT
801
XAI Floating Rate & Alternative Income Trust
XFLT
$289M
$49.4K ﹤0.01%
+1,400
New +$49.7K
AVAV icon
802
AeroVironment
AVAV
$9.45B
$49.2K ﹤0.01%
270
-29
-10% -$5.21K
FRPT icon
803
Freshpet
FRPT
$3.22B
$49K ﹤0.01%
379
-19
-5% -$2.28K
WRB icon
804
W.R. Berkley
WRB
$26.6B
$48.8K ﹤0.01%
932
+21
+2% +$1.13K
HTHT icon
805
Huazhu Hotels Group
HTHT
$13B
$48.8K ﹤0.01%
1,464
-2
-0.1% -$75
CCJ icon
806
Cameco
CCJ
$42.4B
$48.7K ﹤0.01%
990
-80
-7% -$4.06K
SYF icon
807
Synchrony
SYF
$25.6B
$48.5K ﹤0.01%
1,028
WMK icon
808
Weis Markets
WMK
$1.86B
$48.2K ﹤0.01%
768
-115
-13% -$7.34K
RPRX icon
809
Royalty Pharma
RPRX
$25.3B
$48.2K ﹤0.01%
1,828
-572
-24% -$15.9K
MPT
810
Medical Properties Trust
MPT
$2.81B
$48.2K ﹤0.01%
11,183
+3,958
+55% +$19K
AMX icon
811
America Movil
AMX
$71.2B
$48K ﹤0.01%
2,822
-64
-2% -$1.18K
MIDU icon
812
Direxion Daily Mid Cap Bull 3X ETF
MIDU
$79.4M
$47.9K ﹤0.01%
1,000
NOV icon
813
NOV
NOV
$7B
$47.5K ﹤0.01%
2,499
+1,261
+102% +$23.6K
TAP icon
814
Molson Coors Class B
TAP
$8.09B
$47.5K ﹤0.01%
934
+318
+52% +$18.4K
ZS icon
815
Zscaler
ZS
$27.3B
$47.3K ﹤0.01%
246
-3
-1% -$534
TFSL icon
816
TFS Financial
TFSL
$4.93B
$47.3K ﹤0.01%
3,745
+1,034
+38% +$13K
EPR icon
817
EPR Properties
EPR
$4.77B
$47.2K ﹤0.01%
1,125
+185
+20% +$7.61K
TDW icon
818
Tidewater
TDW
$4.12B
$47.1K ﹤0.01%
495
-17
-3% -$1.68K
SNV
819
DELISTED
Synovus
SNV
$47K ﹤0.01%
1,169
+368
+46% +$13.9K
PFC
820
DELISTED
Premier Financial Corp. Common Stock
PFC
$47K ﹤0.01%
2,295
-173
-7% -$3.44K
BALL icon
821
Ball Corp
BALL
$16.8B
$46.9K ﹤0.01%
782
+76
+11% +$5.09K
PSO icon
822
Pearson
PSO
$9.9B
$46.8K ﹤0.01%
3,753
+24
+0.6% +$296
LDOS icon
823
Leidos
LDOS
$17.3B
$46.8K ﹤0.01%
321
+30
+10% +$4.19K
VOD icon
824
Vodafone
VOD
$37.4B
$46.7K ﹤0.01%
5,262
+1,680
+47% +$15K
OKTA icon
825
Okta
OKTA
$25.8B
$46.4K ﹤0.01%
496
-256
-34% -$24.2K

Similar funds

Lindbrook Capital's Q2 2024 Portfolio in Review

As of Q2 2024, Lindbrook Capital held 2,874 positions worth $1.06B, down 0.39% from $1.07B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Lindbrook Capital withdrew a net $36.2M in Q2 2024, closing 115 positions and reducing 630 holdings. Its most notable exit was ProShares UltraPro QQQ, an estimated $1.24M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Lindbrook Capital opened a new position in Nuveen ESG Small-Cap ETF worth $323K.

  • Lindbrook Capital's largest Q2 2024 buy was Nuveen ESG Small-Cap ETF: 8,216 shares worth $323K.
  • Lindbrook Capital added most to State Street SPDR S&P 500 ETF Trust in Q2 2024, an estimated $3.36M increase.
  • Lindbrook Capital's biggest Q2 2024 reduction was Oaktree Specialty Lending, cutting an estimated $12.7M.
  • Lindbrook Capital fully exited ProShares UltraPro QQQ in Q2 2024, selling an estimated $1.24M.
  • Lindbrook Capital's ten largest holdings make up 46% of its $1.06B portfolio in Q2 2024.
  • Lindbrook Capital opened 227 new positions and closed 115 in Q2 2024.
  • Lindbrook Capital's portfolio value fell 0.39% quarter-over-quarter to $1.06B.

Based on Lindbrook Capital's 13F filing for Q2 2024, filed 31 Jul 2024.